Jason Laine

Rescheduling Marijuana: Three Paths, High Stakes 0
- MEDICAL MARIJUANA
- February 12, 2026
Medical marijuana in the U.S. is at a crossroads as federal officials move to shift it from the tightly restricted Schedule I category toward Schedule III, following an executive order signed by President Donald Trump in December 2025 and a process begun under President Joe Biden in 2022. This change could ease research barriers and
READ MORE
Somerset Family Urges NHS to Fund Life-Changing Medical Cannabis 0
- CANNABIS OIL
- February 11, 2026
Emily and Spencer, parents from Nunney near Frome, say medical cannabis has transformed the life of their six-year-old daughter, Clover, who suffers from Aicardi Syndrome. Since starting treatment in 2020, her seizures have drastically reduced—from dozens daily to just a few mild ones—though the family spends £750 a month on privately sourced cannabis oil. After
READ MORE

Marijuana Legalization Edges Closer to U.S. Mainstream 0
- MEDICAL MARIJUANA
- February 6, 2026
Once criminalized nationwide by the Marihuana Tax Act of 1937, cannabis is now legal in some form across most U.S. states, with many authorizing medical use and a growing cohort permitting recreational sales. Yet federal law still classifies marijuana as a Schedule I drug under the Controlled Substances Act, creating a clash between Washington and
READ MORE
CBD Oil for Anxiety: Promise, Limits and Precautions 0
- CANNABIS OIL
- February 4, 2026
Cannabidiol (CBD) oil is emerging as a potential tool for managing anxiety, but experts caution that the evidence remains incomplete and uneven. Recent reviews suggest CBD may ease symptoms in conditions such as generalized and seasonal affective anxiety disorders, with clearer benefits at daily doses in the 300–400 milligram range, though responses vary widely between
READ MORE